Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
J. H. Jeong, S. Chokkakula, S. C. Min, B. Kim, W.-S. Choi, S. Oh, Y. S. Yun, D. H. Kang, O.-J. Lee, E.-G. Kim, J.-H. Choi, J.-Y. Lee, Y. K. Choi, Y. H. Baek, M.-S. Song
This paper evaluates combination antiviral therapies in SARS-CoV-2 infected mice, finding that nirmatrelvir and molnupiravir together significantly improve survival compared to monotherapies.
bioRxiv · Jun 27, 2022Microbiology